Matches in Wikidata for { <http://www.wikidata.org/entity/Q66346462> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q66346462 description "clinical trial" @default.
- Q66346462 description "ensayu clínicu" @default.
- Q66346462 description "klinisch onderzoek" @default.
- Q66346462 description "клінічне випробування" @default.
- Q66346462 name "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 name "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 type Item @default.
- Q66346462 label "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 label "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 prefLabel "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 prefLabel "Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women" @default.
- Q66346462 P1132 Q66346462-48FFF81A-2959-4516-87E6-659EFE966552 @default.
- Q66346462 P1476 Q66346462-0DF25C1F-DF61-4002-B009-DA11BDDC010A @default.
- Q66346462 P17 Q66346462-02450E5F-3511-4308-833D-D0AAFAC411FF @default.
- Q66346462 P17 Q66346462-0750654E-9E50-4B73-986F-81AD2EFAD5D8 @default.
- Q66346462 P17 Q66346462-29B5DB86-5E04-478E-A8F5-EA63D4B50DCE @default.
- Q66346462 P17 Q66346462-3BA94A24-A0AF-4565-9592-A47ED3B1CB86 @default.
- Q66346462 P17 Q66346462-41DEEB15-2A62-41D8-BE00-2F4162887B7A @default.
- Q66346462 P17 Q66346462-5A1258C9-D8A2-4DEC-9B0C-F010BD10EE67 @default.
- Q66346462 P17 Q66346462-A27BC8A9-5951-4E3E-87EE-A9B4761BB83B @default.
- Q66346462 P17 Q66346462-B1D3DB76-4145-4900-8522-B384170A1C7E @default.
- Q66346462 P17 Q66346462-C4D10B40-005F-4743-85FB-2FBD9CDC3C2A @default.
- Q66346462 P17 Q66346462-DEB0180C-6DD2-4596-B4D4-E54E9DD1B9A3 @default.
- Q66346462 P17 Q66346462-FD24504F-6F3E-43C2-A8DF-F8487471751E @default.
- Q66346462 P1813 Q66346462-4C2E0EE2-BE8E-46B1-A5D7-9C9E679BF3B3 @default.
- Q66346462 P2899 Q66346462-20866AB5-AA34-4C88-A96A-ED9B30D3BBD3 @default.
- Q66346462 P3098 Q66346462-DB94AFF7-9809-4C7D-87AE-C5165D0D6353 @default.
- Q66346462 P31 Q66346462-A1DA9387-9F53-4A3F-90C0-DFE07A911BA8 @default.
- Q66346462 P580 Q66346462-313C3B56-2C47-4BCC-98EB-310F565E45C0 @default.
- Q66346462 P582 Q66346462-0430A1B4-732F-4B8F-99FA-8D951E9AED13 @default.
- Q66346462 P6099 Q66346462-335577E5-6725-4F4D-BDB5-4303D506BD25 @default.
- Q66346462 P8363 Q66346462-AA73B1AF-FE77-424E-93D5-DEB02489CE95 @default.
- Q66346462 P1132 "+583" @default.
- Q66346462 P1476 "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women" @default.
- Q66346462 P17 Q1036 @default.
- Q66346462 P17 Q1183 @default.
- Q66346462 P17 Q142 @default.
- Q66346462 P17 Q145 @default.
- Q66346462 P17 Q30 @default.
- Q66346462 P17 Q31 @default.
- Q66346462 P17 Q38 @default.
- Q66346462 P17 Q45 @default.
- Q66346462 P17 Q786 @default.
- Q66346462 P17 Q869 @default.
- Q66346462 P17 Q96 @default.
- Q66346462 P1813 "WAVES" @default.
- Q66346462 P2899 "+18" @default.
- Q66346462 P3098 "NCT01705574" @default.
- Q66346462 P31 Q30612 @default.
- Q66346462 P580 "2012-10-24T00:00:00Z" @default.
- Q66346462 P582 "2015-02-11T00:00:00Z" @default.
- Q66346462 P6099 Q42824827 @default.
- Q66346462 P8363 Q78089383 @default.